MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Advancing LBD Diagnosis: EEG Biomarkers for Cognitive Fluctuations

H. Mayo, A. Negida, M. Ahsan, S. Lageman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

Meeting: 2025 International Congress

Keywords: Dementia with Lewy bodies (DLB), Electroencephalogram(EEG), Parkinson’s

Category: Parkinsonism (Other)

Objective: The objective of the study was to identify EEG features associated with cognitive fluctuations in patients with Lewy body dementia (LBD).

Background: Cognitive fluctuations (CF), defined as spontaneous and time-varying periods of impaired attention and reduced arousal, are a characteristic feature of Lewy body dementia (LBD). An easily obtained and widely available biomarker of CF would greatly advance the ability to diagnose LBD earlier so patients receive timely care. Previous studies suggest specific EEG features correlate with CF and therefore may serve as a diagnostic biomarker.

Method: This prospective cross-sectional study enrolled 50 patients with Parkinson’s disease (PD), PD with dementia and dementia with Lewy bodies.  Participants were divided into LBD with CF (LBDwCF, n=29) and Lewy body disease without CF (LBwoCF, n=21). Resting-state EEG data were processed and analyzed to determine the following features in anterior, temporal, and posterior regions: dominant frequency (DF), dominant frequency variability (DFV) and individual alpha peak frequency (IAF). We used univariate statistical tests, correlational analyses to reduce the model space, multivariate logistic regression models, and elastic net penalty to select the final model to predict CF from EEG feature values. Level of significance was set at p<0.05.

Results: Using correlational analyses, we selected DF-posterior, IAF-posterior, mean DFV, and dominant frequency prevalence – delta (DFP-delta) to reduce multicollinearity among the covariates. LBDwCF had significantly reduced median DF-posterior (6.0, interquartile range (IQR): 5.5-6.9 vs. 8.4, IQR: 7.6-9.2)  and reduced median IAF-posterior (8.0, IQR 8.0-8.4 vs 8.7, IQR: 8.2-10.2) compared to LBwoCF. Only DF-posterior was associated with group after adjustment for age, sex, and Montreal Cognitive Assessment score (OR=0.26, 95% CI: 0.06-0.88, p=0.04). Using elastic net regression with all 4 EEG features, k=100 fold cross validation with 80-20 split, the mean accuracy was 0.86 (95% CI: 0.84-0.88) and the mean AUC was 0.84 (0.82-0.87).

Conclusion: LBDwCF have reduced DF-posterior and IAF-posterior compared to LBwoCF. A model including DF-posterior, IAF-posterior, mean DFV and DFP-delta has good accuracy in predicting CF in Lewy body disease. Incorporating EEG-based biomarkers into clinical practice could improve early diagnosis and management of LBD by providing a non-invasive, accessible tool for detecting CF.

To cite this abstract in AMA style:

H. Mayo, A. Negida, M. Ahsan, S. Lageman, N. Mukhopadhyay, M. Barrett. Advancing LBD Diagnosis: EEG Biomarkers for Cognitive Fluctuations [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/advancing-lbd-diagnosis-eeg-biomarkers-for-cognitive-fluctuations/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/advancing-lbd-diagnosis-eeg-biomarkers-for-cognitive-fluctuations/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley